Key result
Ethanol inhibits secondary ADP-induced platelet aggregation and thromboxane production likely by inhibiting arachidonic acid mobilization.
Why the study?
The effects of ethanol at physiologically tolerable concentrations on different phases and pathways of platelet aggregation were not fully characterized.
Does ethanol inhibit platelet aggregation and secretion in human and rabbit platelets in vitro?
Population
Human and rabbit platelets in vitro
Comparison
Ethanol exposure vs no ethanol exposure
Design
Preclinical in vitro study
Authors
Loading...
In vitro ethanol effects on platelets are hypothesis-generating; leaves open translation to human bleeding or thrombotic risk.
Does ethanol inhibit platelet aggregation and secretion in human and rabbit platelets in vitro?
Ethanol inhibits specific pathways of platelet aggregation, particularly thromboxane A2-dependent secondary aggregation and responses to collagen, thrombin, and PAF.
Rand et al. (1988) studied Platelet aggregation. Ethanol was evaluated on Platelet aggregation and secretion. Ethanol inhibited the secondary phase of ADP-induced aggregation and thromboxane production in human platelets, likely by inhibiting arachidonic acid mobilization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: